Influx Healthtech
INFLUX NSE
Influx Healthtech
HealthcareNSE: INFLUX Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹630 Cr
Volatility
Moderate
P/E Ratio
31
EBITDA
₹29.86 Cr
Return on Equity
36.98%
Debt to Equity
0
Book Value
₹43.52
52W High
₹315
52W Low
₹160.6
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.1%
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 48.1 days to 83.5 days
Growth Rate
Revenue Growth
39.84% higher than
3Y
Net Income Growth
50.07% higher than
3Y
Cash Flow Change
-21.03% lower than
3Y
ROE
-24.3% lower than
3Y
ROCE
-25.01% higher than
3Y
EBITDA Margin (Avg.)
2.18% lower than
3Y
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 48 | 57 | 67 | 80 |
| Expenses | 39 | 45 | 52 | 65 |
| Operating Profit | 9 | 11 | 15 | 15 |
| OPM % | 19% | 20% | 22% | 19% |
| Other Income | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 2 |
| PBT | 8 | 10 | 13 | 14 |
| Tax % | 27% | 24% | 23% | 25% |
| Net Profit | 6 | 8 | 10 | 11 |
| EPS in Rs | 3.1 | 4.21 | 4.32 | 4.56 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 0 | 59 | 76 | 100 | 105 | 147 |
| Expenses | 0 | 53 | 65 | 83 | 84 | 117 |
| Operating Profit | 0 | 6 | 11 | 17 | 21 | 30 |
| OPM % | — | 11% | 14% | 17% | 20% | 20% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 1 | 2 | 3 | 4 |
| PBT | 0 | 6 | 10 | 15 | 18 | 27 |
| Tax % | — | 26% | 26% | 25% | 25% | 25% |
| Net Profit | 0 | 4 | 7 | 11 | 13 | 21 |
| EPS in Rs | 0 | 1,800 | 2,880 | 4,452 | 7.37 | 8.87 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 0.03 | 0.03 | 18 | 23 |
| Reserves | 0 | 4 | 12 | 23 | 18 | 78 |
| Borrowings | 0 | 1 | 1 | 0 | 0 | 0 |
| Other Liabilities | 0 | 12 | 16 | 18 | 34 | 23 |
| Total Liabilities | 0 | 18 | 28 | 41 | 70 | 124 |
| Fixed Assets | 0 | 3 | 6 | 14 | 19 | 28 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 0 | 15 | 22 | 27 | 52 | 90 |
| Total Assets | 0 | 18 | 28 | 41 | 70 | 124 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | 4 | 7 | 9 | 7 | 4 |
| Investing | 0 | -3 | -5 | -8 | -9 | -25 |
| Financing | 0 | 1 | 0 | -1 | 0 | 45 |
| Net Cash Flow | 0 | 1 | 2 | 0 | -2 | 23 |
| Free Cash Flow | 0 | 1 | 2 | 1 | -1 | -21 |
| CFO/OP | — | 89 | 87 | 70 | 56 | 41 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 64 | 66 | 58 | 113 | 84 |
| Inventory Days | — | 14 | 18 | 41 | 112 | 67 |
| Days Payable | — | 88 | 123 | 106 | 248 | 80 |
| Cash Conversion Cycle | — | -10 | -39 | -6 | -24 | 71 |
| Working Capital Days | — | 2 | 1 | 15 | 46 | 83 |
| ROCE % | — | 237% | 111% | 85% | 60% | 40% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Influx Healthtech insights
56 extracted metrics + investor summaries across FY21–FY26.
Documents
1
Updates
10 Sep - 6th AGM on September 18, 2026; annual report FY2025-26 shared, with KYC and email update reminder. 10 Sep - 6th AGM on September 18, 2026; annual report FY2025-26 shared, with KYC and email update reminder.
2
Copy of Newspaper Publication
27 Aug - Published notice for Influx Healthtech’s 6th AGM via VC/OAVM on August 27, 2026. 27 Aug - Published notice for Influx Healthtech’s 6th AGM via VC/OAVM on August 27, 2026.
3
Outcome of Board Meeting
26 Aug - Board approved FY26 Directors’ Report, fixed AGM on September 18, 2026, and appointed scrutinizer. 26 Aug - Board approved FY26 Directors’ Report, fixed AGM on September 18, 2026, and appointed scrutinizer.
4
Shareholders meeting
26 Aug - Influx Healthtech issued FY2025-26 annual report and AGM notice for September 18, 2026. 26 Aug - Influx Healthtech issued FY2025-26 annual report and AGM notice for September 18, 2026.
5
Copy of Newspaper Publication
25 Aug - Newspaper advertisements published for 6th AGM and e-voting instructions on August 25, 2026. 25 Aug - Newspaper advertisements published for 6th AGM and e-voting instructions on August 25, 2026.
Frequently Asked Questions about Influx Healthtech
What does Influx Healthtech Ltd do?
Incorporated in 2020, Influx Healthtech Ltd is a CDMO which deals in nutraceuticals, Ready-to-Drink (RTD) beverages, functional nutrition and pet care.[1]
Where is Influx Healthtech Ltd (INFLUX) listed?
Influx Healthtech Ltd trades as INFLUX on the NSE.
Which sector does Influx Healthtech Ltd belong to?
Influx Healthtech Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Influx Healthtech Ltd?
Influx Healthtech Ltd has a market capitalisation of ₹629.92 Cr, which places it in the Small Cap band.
What is the PE ratio of Influx Healthtech Ltd?
Influx Healthtech Ltd trades at a PE ratio of 31.00, against a book value of ₹43.52 per share.
What is the 52-week high and low of Influx Healthtech Ltd?
Over the last 52 weeks Influx Healthtech Ltd has traded between ₹160.6 and ₹315.
What is the Return on Equity (ROE) of Influx Healthtech Ltd?
Influx Healthtech Ltd reported a return on equity of 36.98%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 2020, Influx Healthtech Ltd is a CDMO which deals in nutraceuticals, Ready-to-Drink (RTD) beverages, functional nutrition and pet care.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INFLUX.md for Influx Healthtech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.